Mobile

A phase III multicentre randomised clinical trial comparing rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone given every 14 days and rituximab with cyclophosphamide, doxorubici...

Mise à jour : Il y a 4 ans
Référence : ISRCTN16017947

A phase III multicentre randomised clinical trial comparing rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone given every 14 days and rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone given every 21 days for the treatment of patients with newly diagnosed diffuse large B cell non-Hodgkin's lymphoma

Extrait

http://www.cancerhelp.org.uk/trials/a-trial-looking-at-treatment-every-2-weeks-or-every-3-weeks-for-non-hodgkins-lymphoma

Critère d'inclusion

  • Diffuse large B-cell lymphoma

Liens